Hsin-Yu Chen Selected Research

Prostatic Neoplasms (Prostate Cancer)

12/2022	Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized 13 C pyruvate metabolic imaging: A technical development study.
1/2022	Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.
1/2020	Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study.
11/2018	Investigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patients.
11/2018	Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer.
1/2017	Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hsin-Yu Chen Research Topics

Disease

19	Neoplasms (Cancer) 12/2023 - 04/2015
6	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 01/2017
4	Glioma (Gliomas) 01/2024 - 01/2020
4	Chronic Renal Insufficiency 11/2022 - 01/2021
3	Wounds and Injuries (Trauma) 12/2023 - 04/2015
3	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2019
3	Infections 10/2023 - 01/2021
3	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2019
3	Lung Neoplasms (Lung Cancer) 09/2018 - 01/2015
2	Infertility (Sterility) 12/2023 - 10/2023
2	Stroke (Strokes) 01/2023 - 04/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 06/2020 - 01/2017
2	Skin Neoplasms (Skin Cancer) 01/2020 - 04/2019
1	Morbid Obesity 03/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Cicatrix (Scar) 12/2023
1	Adenoma (Adenomas) 12/2023
1	Tuberculosis (Tuberculoses) 10/2023
1	Vasculitis (Vasculitides) 10/2023
1	Hemorrhagic Stroke 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 12/2022
1	Latent Tuberculosis 12/2022
1	Hepatitis B 12/2022
1	Bacterial Infections (Bacterial Infection) 12/2022
1	Metabolic Diseases (Metabolic Disease) 12/2022
1	Hypertension (High Blood Pressure) 11/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2022
1	Atopic Dermatitis (Atopic Eczema) 09/2022
1	Thrombosis (Thrombus) 07/2021
1	Hepatocellular Carcinoma (Hepatoma) 07/2021
1	Hemorrhage 04/2021
1	Sepsis (Septicemia) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Cystitis 10/2020
1	Hydronephrosis 10/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Congenital Microtia 08/2019
1	Melanoma (Melanoma, Malignant) 04/2019
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

18	Pyruvic Acid (Pyruvate)IBA 01/2024 - 01/2017
9	Lactic Acid (Lactate)FDA LinkGeneric 12/2023 - 01/2017
4	Carbon-13IBA 01/2020 - 11/2018
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2023 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 01/2017
2	PoisonsIBA 07/2021 - 01/2018
2	CreatinineIBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	Gefitinib (Iressa)FDA Link 09/2018 - 01/2018
1	ulvanIBA 12/2023
1	Matrix Metalloproteinases (MMPs)IBA 12/2023
1	Alanine (L-Alanine)FDA Link 12/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023
1	Inosine Triphosphate (ITP)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	EnzymesIBA 12/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2022
1	Insulin (Novolin)FDA Link 11/2022
1	Immunoglobulin E (IgE)IBA 09/2022
1	HematinicsIBA 01/2022
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Ethiodized Oil (Ethiodol)FDA Link 07/2021
1	Dabigatran FDA Link 04/2021
1	Factor Xa InhibitorsIBA 04/2021
1	apixabanIBA 04/2021
1	AnticoagulantsIBA 04/2021
1	Warfarin (Coumadin)FDA LinkGeneric 04/2021
1	ChlorhexidineIBA 01/2021
1	Ketamine FDA LinkGeneric 10/2020
1	TransferasesIBA 10/2020
1	Alkaline PhosphataseIBA 10/2020
1	CytokinesIBA 06/2020
1	PlatinumIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IsotopesIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	taxaneIBA 01/2020
1	MedporIBA 08/2019
1	chrysinIBA 04/2019
1	benzyl isothiocyanateIBA 09/2018
1	phenethyl isothiocyanate (PEITC)IBA 01/2018
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2018
1	HydrogelsIBA 01/2017

Therapy/Procedure

4	Therapeutics 12/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 07/2021 - 01/2020
2	Renal Dialysis (Hemodialysis) 01/2021 - 01/2020
2	Perforator Flap 01/2017 - 04/2015
1	Gastrectomy 03/2024
1	Aftercare (After-Treatment) 12/2023
1	Endoscopes 12/2023
1	Traction 12/2023
1	Splenectomy 01/2023
1	Long-Term Care 01/2021
1	Hand Hygiene 01/2021
1	Stents 01/2020
1	Castration 01/2020